Translational Modulation of Proteins Expressed from Bicistronic Vectors-Reference-Cited by-同舟云学术

Translational Modulation of Proteins Expressed from Bicistronic Vectors

Published:2009-11 Issue:6 Volume:8 Page:7290.2009.00028
ISSN:1536-0121
Container-title:Molecular Imaging
language:en
Short-container-title:Mol Imaging

Author:

Mishra Prasun J.¹,Menon Lata G.¹,Mishra Pravin J.¹,Mayer-Kuckuk Philipp¹,Bertino Joseph R.¹,Banerjee Debabrata¹

Affiliation:

1. From the Department of Pharmacology, Robert Wood Johnson Medical School, Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD; Department of Medicine, Robert Wood Johnson Medical School, Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Department of Neurosurgery, Brigham and Women's...

Publisher

SAGE Publications

Subject

Condensed Matter Physics,Radiology Nuclear Medicine and imaging,Biomedical Engineering,Molecular Medicine,Biotechnology

Link

http://journals.sagepub.com/doi/pdf/10.2310/7290.2009.00028

Reference31 articles.

1. A Cell Cycle–Dependent Internal Ribosome Entry Site

2. Translational efficiency of EMCV IRES in bicistronic vectors is dependent upon IRES sequence and gene location

3. Functional Characterization of the X-Linked Inhibitor of Apoptosis (XIAP) Internal Ribosome Entry Site Element: Role of La Autoantigen in XIAP Translation

4. Protein Factor Requirements of the Apaf-1 Internal Ribosome Entry Segment: Roles of Polypyrimidine Tract Binding Protein and upstream of N-ras

5. The Apaf-1 Internal Ribosome Entry Segment Attains the Correct Structural Conformation for Function via Interactions with PTB and unr

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of a Solid Tumor Using Engineered Drug-Resistant Immunocompetent Cells and Cytotoxic Chemotherapy;Human Gene Therapy;2012-07

2. Modulation of Immunogenicity and Immunoprotection of Mucosal Vaccine Against Coxsackievirus B3 by Optimizing the Coadministration Mode of Lymphotactin Adjuvant;DNA and Cell Biology;2012-04